BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1563785)

  • 1. Colchicine prevents tumor necrosis factor-induced toxicity in vivo.
    Tiegs G; Freudenberg MA; Galanos C; Wendel A
    Infect Immun; 1992 May; 60(5):1941-5. PubMed ID: 1563785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.
    Tiegs G; Niehörster M; Wendel A
    Biochem Pharmacol; 1990 Sep; 40(6):1317-22. PubMed ID: 2403385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
    Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
    J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
    Matsuura M; Kiso M; Hasegawa A; Nakano M
    Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide (LPS)-induced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause but not fetal sensitivity to LPS.
    Kohmura Y; Kirikae T; Kirikae F; Nakano M; Sato I
    Microbiol Immunol; 2000; 44(11):897-904. PubMed ID: 11145270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolysaccharide in D-galactosamine-sensitized C3H/HeJ mice.
    Tanamoto K
    Infect Immun; 1999 Jul; 67(7):3399-402. PubMed ID: 10377118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
    Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
    Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide (LPS)-induced cell death of C3H mouse peritoneal macrophages in the presence of cycloheximide: different susceptibilities of C3H/HeN and C3H/HeJ mice macrophages.
    Karahashi H; Amano F
    J Endotoxin Res; 2000; 6(1):33-9. PubMed ID: 11061030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
    Lehmann V; Freudenberg MA; Galanos C
    J Exp Med; 1987 Mar; 165(3):657-63. PubMed ID: 3819645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS.
    Kirikae T; Nitta T; Kirikae F; Suda Y; Kusumoto S; Qureshi N; Nakano M
    Infect Immun; 1999 Apr; 67(4):1736-42. PubMed ID: 10085012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.
    Kirikae F; Kirikae T; Qureshi N; Takayama K; Morrison DC; Nakano M
    Infect Immun; 1995 Feb; 63(2):486-97. PubMed ID: 7529746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.
    Freudenberg MA; Galanos C
    Infect Immun; 1991 Jun; 59(6):2110-5. PubMed ID: 2037372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin tolerance from lipopolysaccharide pretreatment induces nuclear factor-kappaB alterations not present in C3H/HeJ mice.
    West MA; Clair L; Kraatz J; Rodriguez JL
    J Trauma; 2000 Aug; 49(2):298-305. PubMed ID: 10963543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.
    Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF
    Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages.
    Freudenberg MA; Galanos C
    Infect Immun; 1988 May; 56(5):1352-7. PubMed ID: 3356468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha.
    Silver RM; Lohner WS; Daynes RA; Mitchell MD; Branch DW
    Biol Reprod; 1994 May; 50(5):1108-12. PubMed ID: 8025168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Tiegs G; Wolter M; Wendel A
    Biochem Pharmacol; 1989 Feb; 38(4):627-31. PubMed ID: 2465008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of tumor necrosis factor-alpha and glucocorticoid in hydrazine sulfate-mediated protection against endotoxin lethality.
    Johnson DC; Freudenberg MA; Jia F; Gonzalez JC; Galanos C; Morrison DC; Silverstein R
    Circ Shock; 1994 May; 43(1):1-8. PubMed ID: 7982269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality.
    Bucklin SE; Silverstein R; Morrison DC
    Infect Immun; 1993 Aug; 61(8):3184-9. PubMed ID: 8335348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.